Life with Type 1 Diabetes,
medical research and the search for a cure

Path to a Cure is kindly supported by Novo Nordisk

Posts Tagged ‘vaccine’

human clinical trial t1d Prevention Trial: Participants NeededThe JDRF-funded Type 1 Diabetes Prevention Trial is a groundbreaking medical trial that aims to determine if the risk of getting type 1 diabetes can be eliminated by a nasal insulin vaccine. The trial is now into its fifth year and has screened over six thousand people in Australia and New Zealand to assess eligibility, with 58 eligible people now participating in the trial.

The trial is looking for more volunteers to reach their goal of 12,000! To participate in the initial screening test, you will need to be aged between 4 – 30 years with a relative with type 1 diabetes. This first step will be a free blood test for antibodies that may indicate a future risk of getting type 1 diabetes.

Read more...

dr pere santamaria New vaccine safely stops beta cell attackJDRF researchers from Canada show that a new vaccine can cure type 1 diabetes in mice and slow the onset of the condition in mice at risk of the disease.

Type 1 diabetes is caused when a persons own immune system attacks and destroys the insulin-producing cells in the pancreas. Whilst the precise trigger of this attack is still unproven, researchers do know that there are certain immune cells that play a more important role than others. The challenge is to target the “bad” cells without harming the good cells that protect us from day-to-day infections.

Read more...

Type 1 Diabetes Prevention Study

family100 Type 1 Diabetes Prevention StudyAre you under 30 years of age and have a relative with type 1 diabetes? Perhaps you have type 1 diabetes yourself and have family members that would like to make a contribution towards a cure.

The Type 1 Diabetes Prevention Trial is an exciting study being run across Australia and New Zealand by the Diabetes Vaccine Development Centre (DVDC). Investigators are using an insulin nasal spray vaccine to try to protect people who are genetically at risk of type 1 diabetes.

Read more...

For many years, researchers have suspected that bacteria, viruses and other micro-organisms play an important role in the development of autoimmune conditions such as type 1 diabetes. This “hygiene hypothesis” postulates that our decreasing exposure to a lower amount of bugs and germs may leave some people more susceptible to autoimmune attacks.

A team of researchers from Yale University in the US have leant further support to this hypothesis by demonstrating that a certain strain of research mice were far more likely to develop type 1 diabetes when raised in a special germ-free environment as opposed to normal laboratory conditions.

Read more...